| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/03/1991 | WO1991015593A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 10/03/1991 | WO1991014775A1 Gp75 as a tumor vaccine for melanoma |
| 10/03/1991 | WO1991014769A1 Catalytic antibody components |
| 10/03/1991 | WO1991014451A1 Bcrf1 antagonists for treating epstein-barr virus infections |
| 10/03/1991 | WO1991014450A1 Use of il-4 to enhance immune response to infectious antigenic challenges |
| 10/03/1991 | WO1991014449A1 Induction of protection against viral infection |
| 10/03/1991 | WO1991014448A1 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis |
| 10/03/1991 | WO1991014438A1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 10/03/1991 | WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof |
| 10/03/1991 | WO1991010735A3 Human receptor of tsh. sequence coding for such receptor |
| 10/03/1991 | CA2078676A1 Use of il-4 to enhance immune response to infectious antigenic challenges |
| 10/03/1991 | CA2078131A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 10/03/1991 | CA2057040A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
| 10/02/1991 | EP0449769A1 CD 25 binding molecules |
| 10/02/1991 | EP0449116A1 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof |
| 10/02/1991 | EP0448605A1 Use of basic amino acids to solubilize immunoglobulins |
| 10/01/1991 | CA1289952C N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas, processes for their preparation, and their use in medicaments |
| 10/01/1991 | CA1289881C Vaccine against herpes simplex |
| 10/01/1991 | CA1289880C Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 10/01/1991 | CA1289870C Method of assaying myosin light chain |
| 09/30/1991 | WO1991014703A1 Hepatitis b vaccine |
| 09/30/1991 | CA2039231A1 Anti-oncostatin m monoclonal antibodies |
| 09/28/1991 | WO1991014452A1 Method for inhibiting cell growth and compositions useful therefor |
| 09/28/1991 | CA2081368A1 Method for inhibiting cell growth and compositions useful therefor |
| 09/27/1991 | WO1991014459A1 A bifunctional dtpa-type ligand |
| 09/25/1991 | EP0448180A2 A method of modulating the production of secondary metabolites |
| 09/25/1991 | EP0448126A1 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 09/25/1991 | EP0448095A1 Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections |
| 09/25/1991 | EP0448075A1 Immunoglobulin G and process for the production thereof |
| 09/25/1991 | EP0448057A1 Monoclonal antibody reactive with a novel HLA determinant on MHC class I molecules and method for activating lymphocytes |
| 09/25/1991 | EP0447984A1 Hyperimmune globulin against hepatitis C virus and method for making same |
| 09/25/1991 | EP0447956A1 Plasmodium sporozoite antigen |
| 09/25/1991 | EP0447585A1 Process for manufacturing an intravenously tolerant immunoglobulin-G preparation |
| 09/25/1991 | EP0447489A1 Human platelet-specific antibodies |
| 09/25/1991 | EP0447424A1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 09/25/1991 | EP0118462B1 Stabilized gamma globulin concentrate |
| 09/25/1991 | CN1054772A Synthetic polypeptides |
| 09/24/1991 | US5051496 Polypeptides encoded by DNA fragments for detection of AIDS |
| 09/24/1991 | US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems |
| 09/24/1991 | US5051355 Anti-human gastric cancer monoclonal antibody |
| 09/24/1991 | US5051254 Immunoprophylactic polypeptides for schistosomiasis |
| 09/24/1991 | CA2038911A1 Catalytic antibody components |
| 09/24/1991 | CA2037151A1 Plasmodium sporozoite antigen |
| 09/24/1991 | CA1289492C Process for the production of chymosin |
| 09/24/1991 | CA1289474C Antibodies useable as pilot agents, and compounds containing same |
| 09/21/1991 | CA2038581A1 Seroreactive epitopes of human papillomavirus (hpv) 16 proteins |
| 09/21/1991 | CA2038534A1 Hyperimmune globulin against hepatitis c virus and method for making same |
| 09/20/1991 | CA2332618A1 Liquid lavage/ventilation of the pulmonary system |
| 09/20/1991 | CA2038397A1 Monoclonal antibody reactive with a novel hla determinant on mhc class i molecules and method for activating lymphocytes |
| 09/19/1991 | WO1991013987A1 Cdna coding for the gene n of the viral haemorrhagic septicaemia virus and utilizations thereof |
| 09/19/1991 | WO1991013985A1 Leukaemia inhibitory factor |
| 09/19/1991 | WO1991013978A1 Vaccines for preventing furunculosis in fish |
| 09/19/1991 | WO1991013633A1 Improvements relating to immunoradiotherapy |
| 09/19/1991 | WO1991013632A1 Idiotypic vaccination against b cell lymphoma |
| 09/19/1991 | WO1991013631A1 Method for enhancing antibody transport through capillary barriers |
| 09/19/1991 | WO1991013630A1 ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI) |
| 09/19/1991 | WO1991013629A1 Use of lactoferrin to counter the toxic effects of endotoxins |
| 09/19/1991 | CA2078128A1 Vaccines for preventing furunculosis in fish |
| 09/18/1991 | EP0447353A1 A pharmaceutical preparation for the maturation of prothymocytes |
| 09/18/1991 | EP0447322A2 A process for preparing a purified Treponemal antigen and use thereof |
| 09/18/1991 | EP0447303A1 Recombinant herpes viruses, particularly for realization of vaccines, preparation process therefor, realized plasmids during this process and obtained vaccines |
| 09/18/1991 | EP0446797A2 Synthetic peptides containing factor VIIa sequences and their use |
| 09/18/1991 | EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody |
| 09/18/1991 | EP0446283A1 Synthetic interleukin-6 |
| 09/18/1991 | EP0446273A1 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 09/18/1991 | EP0446272A1 EXPRESSION OF HIV PROTEINS IN $i(DROSOPHILA) CELLS |
| 09/18/1991 | CN1054615A Hepatocellular carcinoma oncogene |
| 09/18/1991 | CN1054613A Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses |
| 09/17/1991 | US5049659 Proteins which induce immunological effector cell activation and chemattraction |
| 09/17/1991 | US5049656 Capping |
| 09/17/1991 | US5049392 Osmotically dependent vesicles |
| 09/17/1991 | US5049390 Liposome containing immunotherapy agents for treating IgE mediated allergies |
| 09/17/1991 | US5049373 Immunology |
| 09/16/1991 | WO1991013909A1 Synthetic polypeptides |
| 09/16/1991 | CA2078220A1 Synthetic polypeptides |
| 09/13/1991 | WO1991013995A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
| 09/13/1991 | CA2055489A1 Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained |
| 09/12/1991 | DE4007315A1 Use of zinc-calcium hydroxide gel, lecithin and poly-alpha-olefin! - as adjuvants to increase immunogenicity of antigens, are of low toxicity and work synergistically |
| 09/11/1991 | EP0446071A2 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis |
| 09/11/1991 | EP0446017A1 New diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/11/1991 | EP0445710A1 Use of zinc-calcium hydroxyde, lecithin and PAO for adjuvating antigen solutions and antigen solutions adjuvated in this way |
| 09/11/1991 | EP0445625A1 Human monoclonal antibody against rabies virus, its production and use |
| 09/11/1991 | EP0445228A1 Immunotherapy involving cd28 stimulation |
| 09/11/1991 | EP0445227A1 Position-specific insertion vectors and method of using same |
| 09/11/1991 | EP0445128A1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them. |
| 09/10/1991 | WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
| 09/10/1991 | WO1991013906A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 09/10/1991 | US5047507 Diagnosis And Therapy Of Cancer |
| 09/10/1991 | US5047330 Compound labelled by the acetyl cholinesterase of Electrophorus electricus, its preparation process and its use as a tracer or marker in enzymoimmunological determinations |
| 09/10/1991 | US5047238 Ethylene-Maleic Anhydride Copolymer or Uncoalesced Acrylic Polymer |
| 09/10/1991 | US5047237 Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
| 09/10/1991 | CA2037835A1 Tri-functional antibody-like compounds as a combined diagnostic and therapeutics agent |
| 09/10/1991 | CA2037811A1 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis |
| 09/10/1991 | CA1288896C Immunoglobulin conjugates |
| 09/10/1991 | CA1288688C Method for the diagnosis and treatment of inflammation |
| 09/06/1991 | CA2037478A1 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/05/1991 | WO1991013155A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 09/05/1991 | WO1991013148A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
| 09/05/1991 | WO1991012886A1 Immobilized polyethylene oxide star molecules for bioapplications |